NCT01477203
- Conditions
- Anxiety Disorder, Anxiety Disorders, Depressive Disorder, +4 more
- Locations
-
- Medical University of Vienna, Department for Psychiatrie and Psychotherapie Vienna, State of Vienna, Austria
Clinical trial condition
Major Depressive Disorder (MDD)
Explore clinical trials studying Major Depressive Disorder (MDD). Study availability and eligibility vary by location and protocol.
166 public trials
63 recruiting studies
Major Depressive Disorder (MDD) trial results
Completed
Depression Study In Elderly Patients
NCT00067444
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Anaheim, California, United States
- GSK Investigational Site Beverly Hills, California, United States
- GSK Investigational Site El Centro, California, United States
NCT01912196
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
- Locations
-
- MSI Investigational Site Birmingham, Alabama, United States
- MSI Investigational Site Encino, California, United States
- MSI Investigational Site Escondido, California, United States
- MSI Investigational Site Garden Grove, California, United States
NCT02012218
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Collaborative NeuroScience Network, Inc. Garden Grove, California, United States
- Viking Clinical Research, Ltd. Temecula, California, United States
- Clinical Neuroscience Solutions Pharmacology Orlando, Florida, United States
- Carman Research Smyrna, Georgia, United States
NCT01790919
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- University of California, Berkeley Berkeley, California, United States
NCT00330616
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- GSK Investigational Site Fukuoka, Japan
- GSK Investigational Site Fukushima, Japan
- GSK Investigational Site Kumamoto, Japan
- GSK Investigational Site Nagano, Japan
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
- Locations
-
- Duke University Medical Center / Civitan Building Durham, North Carolina, United States
NCT00102492
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Beverly Hills, California, United States
- GSK Investigational Site Fort Lauderdale, Florida, United States
NCT00960986
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cheong Ju-City, South Korea
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-si, South Korea
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seongnam-si, South Korea
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, South Korea
NCT00958204
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- UBC Hospital Mood Disorders Centre Vancouver, British Columbia, Canada